scispace - formally typeset
A

Andrew K. Davey

Researcher at Griffith University

Publications -  97
Citations -  2597

Andrew K. Davey is an academic researcher from Griffith University. The author has contributed to research in topics: Warfarin & Pyocyanin. The author has an hindex of 26, co-authored 94 publications receiving 2197 citations. Previous affiliations of Andrew K. Davey include University of Otago & Monash University, Parkville campus.

Papers
More filters
Journal ArticleDOI

Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa.

TL;DR: It has been postulated that, given its chemical properties, PCN is able to readily cross biological membranes, however studies have yet to be undertaken to evaluate this effect, and this review highlights the possible manifestations of PCN exposure.
Journal ArticleDOI

Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.

TL;DR: It is postulated that SLH microcapsules improve CEL oral absorption via dissolution enhancement, potentially in conjunction with other unexplored mechanisms, hence offering the possibility of dose reduction for improved therapeutic efficacy and cost-effectiveness of poorly soluble drugs.
Journal ArticleDOI

Molecular mechanisms underlying the effects of statins in the central nervous system

TL;DR: An updated discussion on the molecular mechanisms contributing to statins’ possible effects on cognitive function, neurodegenerative disease, and various neurological disorders such as stroke, epilepsy, depression and CNS cancers is provided.
Journal ArticleDOI

Surgical adhesions: a timely update, a great challenge for the future.

TL;DR: Strategies to reduce adhesion formation include improving surgical techniques, optimizing laparoscopy conditions, using pharmacologic interventions targeted at the inflammatory response and/or fibrin deposition, and using agents that provide a physical barrier toAdhesion formation.
Journal ArticleDOI

Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.

TL;DR: The hybrid lipid-silica microcapsules improve oral absorption by enhancing lipolysis and drug dissolution and showed the highest maximum plasma concentration (C(max)) among the investigated formulations.